title: Reply to the comment of Brinster et al. "Acquired hemophilia, rheumatoid arthritis, and TNFα antagonists".
authors.affiliation: Service de rhumatologie, CHU-Hôpitaux de Rouen, 147, avenue du Maréchal-Juin, 76230 Bois-Guillaume, France; Inserm U905, CRB CIC 1404, IRIB, université de Rouen, 76031 Rouen cedex, France. Electronic address: totobanse@orange.fr.
authors.forename: Christopher
authors.initials: C
authors.lastname: Banse
authors.affiliation: Service de rhumatologie, CHU-Hôpitaux de Rouen, 147, avenue du Maréchal-Juin, 76230 Bois-Guillaume, France; Inserm U905, CRB CIC 1404, IRIB, université de Rouen, 76031 Rouen cedex, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Vittecoq
authors.affiliation: Inserm U1096, IRIB, service de médecine interne, CHU-Hôpitaux de Rouen, université de Rouen, 76031 Rouen cedex, France.
authors.forename: Hervé
authors.initials: H
authors.lastname: Lévesque
mesh_terms: D018501:Antirheumatic Agents / Q000009:adverse effects*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D000068800:Etanercept / Q000009:adverse effects*; D005260:Female; D006467:Hemophilia A / Q000139:chemically induced*; D006801:Humans
chemical_list: D018501:Antirheumatic Agents; D000068800:Etanercept
keywords: Acquired hemophilia; Biotherapy; Etiology; Rheumatoid arthritis; TNFα antagonists